Clinical trial
Ipilimumab and Sargramostim in Treating Patients With Metastatic Prostate Cancer
NCT00064129
Study timeline
Study start (actual)2003-05-13Date precision: day
Registry last updated2020-07-30
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Recurrent Prostate Carcinomaunresolved
Stage IV Prostate Cancer AJCC v7unresolved
Interventions
IpilimumabBIOLOGICAL
SargramostimBIOLOGICAL
Sponsors & collaborators
National Cancer Institute (NCI)lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00064129 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.